Header Logo

Sefer Gezer

Concepts (155)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myelodysplastic Syndromes
15
2004
32
0.610
Why?
Antiphospholipid Syndrome
1
2003
5
0.230
Why?
Bone Marrow
10
2001
79
0.210
Why?
Apoptosis
8
1999
193
0.190
Why?
Thrombosis
1
2021
51
0.180
Why?
Thalidomide
3
2004
6
0.160
Why?
Tumor Necrosis Factor-alpha
4
2004
185
0.130
Why?
Leukemia, Myeloid, Acute
4
2001
49
0.130
Why?
Antineoplastic Agents
3
2004
176
0.120
Why?
Leukemia, Promyelocytic, Acute
2
1998
4
0.120
Why?
Tretinoin
2
1998
14
0.120
Why?
Interphase
4
1990
5
0.110
Why?
Blood Coagulation
1
2011
17
0.090
Why?
Genetic Testing
1
2011
52
0.090
Why?
Cytokines
4
2001
226
0.090
Why?
Venous Thrombosis
1
2011
43
0.090
Why?
Pulmonary Embolism
1
2011
60
0.090
Why?
Hematopoietic Stem Cells
4
1999
11
0.080
Why?
Humans
26
2021
26017
0.080
Why?
Biomarkers
2
2011
549
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2000
224
0.080
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
9
0.080
Why?
Male
13
2011
14005
0.070
Why?
Cell Cycle
3
1997
33
0.060
Why?
Bromodeoxyuridine
3
1997
8
0.060
Why?
Antibodies, Monoclonal
2
2004
192
0.060
Why?
Female
11
2011
14395
0.060
Why?
Proto-Oncogenes
1
2004
4
0.060
Why?
Arsenicals
1
2004
11
0.060
Why?
Oxides
1
2004
15
0.060
Why?
Immunosuppressive Agents
2
2004
122
0.060
Why?
Aged
11
2011
8703
0.060
Why?
Drug Resistance, Neoplasm
1
2004
61
0.060
Why?
Pilot Projects
4
2011
377
0.060
Why?
Transcription Factors
1
2004
159
0.050
Why?
Arthroplasty, Replacement, Knee
1
2011
620
0.050
Why?
Transforming Growth Factor beta
3
2001
92
0.050
Why?
DNA-Binding Proteins
1
2004
254
0.050
Why?
Middle Aged
10
2011
8505
0.050
Why?
Aged, 80 and over
7
2011
4658
0.050
Why?
Prevalence
1
2003
433
0.050
Why?
Adult
6
2021
7362
0.050
Why?
Cytarabine
3
2001
11
0.050
Why?
Bone Marrow Cells
1
2001
50
0.050
Why?
Blood Transfusion
1
2001
64
0.050
Why?
DNA, Neoplasm
2
1998
16
0.040
Why?
Anemia
1
2001
93
0.040
Why?
Connective Tissue
2
1996
21
0.040
Why?
Palliative Care
1
2000
104
0.040
Why?
Cytogenetic Analysis
3
2004
5
0.040
Why?
Remission Induction
3
2004
88
0.040
Why?
Hematopoiesis
4
2001
11
0.040
Why?
Ecchymosis
1
1998
2
0.040
Why?
Cell Division
4
2001
79
0.040
Why?
Severity of Illness Index
1
2021
929
0.040
Why?
Idoxuridine
1
1997
1
0.040
Why?
Cell Lineage
3
2004
22
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
10
0.030
Why?
Cysteine Endopeptidases
1
1996
5
0.030
Why?
Endopeptidases
1
1996
15
0.030
Why?
Leukemia, Myeloid
2
1995
4
0.030
Why?
DNA
3
1997
93
0.030
Why?
Treatment Outcome
5
2004
3292
0.030
Why?
Macrophages
3
2001
104
0.030
Why?
Tumor Cells, Cultured
2
1992
116
0.030
Why?
Phenotype
2
2011
290
0.030
Why?
Risk Factors
2
2011
2242
0.020
Why?
Time Factors
2
2001
1365
0.020
Why?
Hemoglobins
2
2001
74
0.020
Why?
Mitoxantrone
2
2001
4
0.020
Why?
Blood Cell Count
2
2001
12
0.020
Why?
Pedigree
1
2011
55
0.020
Why?
Chi-Square Distribution
1
2011
133
0.020
Why?
Amifostine
2
2000
3
0.020
Why?
Monosomy
1
1990
1
0.020
Why?
Leukemia, Monocytic, Acute
1
1990
3
0.020
Why?
Preoperative Care
1
2011
121
0.020
Why?
Chromosome Deletion
1
1990
16
0.020
Why?
Case-Control Studies
2
2001
550
0.020
Why?
Anticoagulants
1
2011
86
0.020
Why?
Antigens, CD34
2
2001
11
0.020
Why?
Patient Selection
1
2011
193
0.020
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1989
8
0.020
Why?
Antigens, Neoplasm
1
1989
38
0.020
Why?
Nucleoproteins
1
1988
2
0.020
Why?
Superoxides
1
1988
23
0.020
Why?
Genetic Predisposition to Disease
1
2011
373
0.020
Why?
Fatal Outcome
1
2008
50
0.020
Why?
Disease Progression
2
2004
685
0.020
Why?
Cell Differentiation
1
1988
124
0.020
Why?
Risk Assessment
1
2011
622
0.020
Why?
Chicago
1
2011
844
0.020
Why?
DNA Fragmentation
2
1996
5
0.020
Why?
DNA Replication
2
1996
10
0.020
Why?
S Phase
2
1999
8
0.020
Why?
Interleukin-1
2
1996
46
0.020
Why?
Surveys and Questionnaires
1
2011
1068
0.020
Why?
Anemia, Refractory
1
2004
1
0.020
Why?
Pancytopenia
1
2004
2
0.020
Why?
Chromosome Aberrations
1
2004
13
0.010
Why?
Infliximab
1
2004
16
0.010
Why?
MDS1 and EVI1 Complex Locus Protein
1
2004
3
0.010
Why?
Zinc Fingers
1
2004
12
0.010
Why?
Spleen
1
2004
31
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
119
0.010
Why?
Drug Therapy, Combination
1
2004
170
0.010
Why?
Patient Compliance
1
2004
145
0.010
Why?
Acute Disease
2
1995
189
0.010
Why?
Lymphokines
1
2001
8
0.010
Why?
Platelet Count
1
2001
15
0.010
Why?
Transforming Growth Factor alpha
1
2001
8
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
13
0.010
Why?
Endothelial Growth Factors
1
2001
9
0.010
Why?
Coculture Techniques
1
2001
27
0.010
Why?
Fetal Blood
1
2001
13
0.010
Why?
Adipocytes
1
2001
12
0.010
Why?
Endothelium
1
2001
11
0.010
Why?
Microscopy, Electron
1
2001
65
0.010
Why?
Cell Culture Techniques
1
2001
30
0.010
Why?
Maximum Tolerated Dose
1
2001
13
0.010
Why?
Fibroblasts
1
2001
56
0.010
Why?
Stromal Cells
1
2001
31
0.010
Why?
Vascular Endothelial Growth Factor A
1
2001
66
0.010
Why?
Drug Administration Schedule
1
2001
156
0.010
Why?
Immunohistochemistry
1
2001
335
0.010
Why?
Radiation-Protective Agents
1
2000
3
0.010
Why?
Anorexia
1
2000
2
0.010
Why?
Pentoxifylline
1
2000
6
0.010
Why?
Ciprofloxacin
1
2000
12
0.010
Why?
Hematologic Diseases
1
2000
11
0.010
Why?
Hypotension
1
2000
27
0.010
Why?
Dexamethasone
1
2000
32
0.010
Why?
Gastrointestinal Diseases
1
2000
34
0.010
Why?
Karyotyping
1
1999
8
0.010
Why?
In Situ Nick-End Labeling
1
1999
14
0.010
Why?
Age Factors
1
2001
744
0.010
Why?
Prognosis
1
2000
750
0.010
Why?
Sialoglycoproteins
1
1996
9
0.010
Why?
Cysteine Proteinase Inhibitors
1
1996
6
0.010
Why?
Interleukin 1 Receptor Antagonist Protein
1
1996
13
0.010
Why?
Oligopeptides
1
1996
22
0.010
Why?
Caspase 1
1
1996
16
0.010
Why?
Diagnosis, Differential
1
1998
342
0.010
Why?
Leukemia
1
1996
4
0.010
Why?
Lymphoma, Non-Hodgkin
1
1996
37
0.010
Why?
Cohort Studies
1
2001
1822
0.010
Why?
Biopsy
1
1995
199
0.010
Why?
Models, Biological
1
1996
303
0.010
Why?
Adolescent
1
1999
2064
0.010
Why?
Tritium
1
1992
7
0.010
Why?
Dose-Response Relationship, Drug
1
1992
315
0.010
Why?
Metaphase
1
1990
2
0.010
Why?
Nucleic Acid Hybridization
1
1990
7
0.010
Why?
Chromosome Mapping
1
1990
26
0.010
Why?
Regeneration
1
1989
20
0.000
Why?
Gezer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (155)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_